{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:46:26Z","timestamp":1791971186790,"version":"4.3.4"},"reference-count":162,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Insight"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cellin.2026.100360","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:58:07Z","timestamp":1789253887000},"page":"100360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From DNA damage to systemic immunity: Interaction networks in radio-immunotherapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Ruixue","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.cellin.2026.100360_bib1","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.medj.2024.10.004","article-title":"ADRIATIC: When face value is enough","volume":"5","author":"Addeo","year":"2024","journal-title":"Med"},{"issue":"7","key":"10.1016\/j.cellin.2026.100360_bib2","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3390\/ijms26073117","article-title":"The potential of peptide-based inhibitors in disrupting protein\u2013protein interactions for targeted cancer therapy","volume":"26","author":"Afonso","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.cellin.2026.100360_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s12094-025-04051-4","article-title":"Harnessing biomarkers to guide immunotherapy in esophageal cancer: Toward precision oncology","volume":"28","author":"Almars","year":"2025","journal-title":"Clinical and Translational Oncology"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12551-023-01137-7","article-title":"Protein\u2013DNA recognition mechanisms and specificity","volume":"15","author":"Anashkina","year":"2023","journal-title":"Biophysical Reviews"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib5","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1038\/s41467-019-11906-2","article-title":"Tumor-reprogrammed resident T cells resist radiation to control tumors","volume":"10","author":"Arina","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.cellin.2026.100360_bib6","first-page":"55","article-title":"Immune system in residents of territories contaminated with radionuclides after Chernobyl accident","volume":"70","author":"Asfandiiarova","year":"1998","journal-title":"Terapevticheskii Arkhiv"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00011-012-0567-y","article-title":"The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells","volume":"62","author":"Balogh","year":"2013","journal-title":"Inflammation Research"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrm.2017.7","article-title":"Biomolecular condensates: Organizers of cellular biochemistry","volume":"18","author":"Banani","year":"2017","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000537","article-title":"Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma","volume":"8","author":"Barsoumian","year":"2020","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1667\/RR2160.1","article-title":"Effects of low-dose radiation on the immune system of mice after total-body irradiation","volume":"174","author":"Bogd\u00e1ndi","year":"2010","journal-title":"Radiation Research"},{"issue":"3","key":"10.1016\/j.cellin.2026.100360_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41573-018-0011-2","article-title":"Interferons \u03b1 and \u03b2 in cancer: Therapeutic opportunities from new insights","volume":"18","author":"Borden","year":"2019","journal-title":"Nature Reviews Drug Discovery"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000627","article-title":"Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma","volume":"8","author":"Boutros","year":"2020","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"8","key":"10.1016\/j.cellin.2026.100360_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: From biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nature Reviews Cancer"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.molcel.2014.03.040","article-title":"The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling","volume":"54","author":"Cai","year":"2014","journal-title":"Molecular Cell"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijrobp.2022.07.1841","article-title":"Ionizing radiation triggers the antitumor immunity by inducing gasdermin E-Mediated pyroptosis in tumor cells","volume":"115","author":"Cao","year":"2023","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"10405","key":"10.1016\/j.cellin.2026.100360_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: An open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"The Lancet"},{"issue":"26","key":"10.1016\/j.cellin.2026.100360_bib17","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.cellin.2026.100360_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2022.11.035","article-title":"Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)","volume":"180","author":"Chen","year":"2023","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1016\/j.cellin.2026.100360_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ccell.2025.02.010","article-title":"Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-023-01422-8","article-title":"Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: A prospective cohort study","volume":"16","author":"Chen","year":"2023","journal-title":"Journal of Hematology & Oncology"},{"issue":"11","key":"10.1016\/j.cellin.2026.100360_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2023.101279","article-title":"Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial","volume":"4","author":"Chen","year":"2023","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.cellin.2026.100360_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251387534","article-title":"Molecular mechanisms underlying the abscopal effect induced by radiotherapy and its synergistic translational potential with immunotherapy","volume":"17","author":"Chen","year":"2025","journal-title":"Therapeutic Advances in Medical Oncology"},{"key":"10.1016\/j.cellin.2026.100360_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107734","article-title":"Artificial intelligence in central-peripheral interaction organ crosstalk: The future of drug discovery and clinical trials","volume":"215","author":"Chen","year":"2025","journal-title":"Pharmacological Research"},{"issue":"10","key":"10.1016\/j.cellin.2026.100360_bib24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/biomedicines9101349","article-title":"Irradiation mediates IFN\u03b1 and CXCL9 expression in non-small cell lung cancer to stimulate CD8+ T cells activity and migration toward tumors","volume":"9","author":"Cheng","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cellin.2026.100360_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115332","article-title":"Novel strategies for modulating the gut microbiome for cancer therapy","volume":"210","author":"Cho","year":"2024","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"6","key":"10.1016\/j.cellin.2026.100360_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/2326-6066.CIR-22-0306","article-title":"Randomized phase II study evaluating the addition of pembrolizumab to Radium-223 in metastatic castration-resistant prostate cancer","volume":"12","author":"Choudhury","year":"2024","journal-title":"Cancer Immunology Research"},{"issue":"3","key":"10.1016\/j.cellin.2026.100360_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","article-title":"Humanized mouse models for immuno-oncology research","volume":"20","author":"Chuprin","year":"2023","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"22","key":"10.1016\/j.cellin.2026.100360_bib28","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1158\/1078-0432.CCR-20-0572","article-title":"Radiation-induced adaptive response: New potential for cancer treatment","volume":"26","author":"Coleman","year":"2020","journal-title":"Clinical Cancer Research"},{"issue":"6165","key":"10.1016\/j.cellin.2026.100360_bib29","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","article-title":"Cancer immunotherapy","volume":"342","author":"Couzin-Frankel","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cellin.2026.100360_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1409300","article-title":"The future of cancer treatment: Combining radiotherapy with immunotherapy","volume":"11","author":"Dagar","year":"2024","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202308174","article-title":"Landscape of the peripheral immune response induced by intraoperative radiotherapy combined with surgery in early breast cancer patients","volume":"12","author":"Dai","year":"2025","journal-title":"Advanced Science"},{"issue":"12","key":"10.1016\/j.cellin.2026.100360_bib32","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1172\/JCI25947","article-title":"Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells","volume":"115","author":"Dannull","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/biomedicines12040819","article-title":"Analysing the combined effects of radiotherapy and chemokine receptor 5 antagonism: Complementary approaches to promote T cell function and migration in oesophageal adenocarcinoma","volume":"12","author":"Davern","year":"2024","journal-title":"Biomedicines"},{"issue":"31","key":"10.1016\/j.cellin.2026.100360_bib34","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1200\/JCO.22.02894","article-title":"Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis (the PERICLES study): A phase II trial","volume":"41","author":"de Vries","year":"2023","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1016\/j.cellin.2026.100360_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2567.2007.02589.x","article-title":"A subset of functional effector-memory CD8+ T lymphocytes in human immunodeficiency virus-infected patients","volume":"121","author":"Decrion","year":"2007","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.cellin.2026.100360_bib37","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.ymthe.2018.09.008","article-title":"Low-dose radiation conditioning enables CAR T cells to mitigate antigen escape","volume":"26","author":"DeSelm","year":"2018","journal-title":"Molecular Therapy"},{"issue":"8","key":"10.1016\/j.cellin.2026.100360_bib38","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-17-0581","article-title":"Exosomes shuttle TREX1-Sensitive IFN-stimulatory dsDNA from irradiated cancer cells to DCs","volume":"6","author":"Diamond","year":"2018","journal-title":"Cancer Immunology Research"},{"issue":"7","key":"10.1016\/j.cellin.2026.100360_bib39","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.str.2013.05.013","article-title":"Single-stranded DNA-binding proteins: Multiple domains for multiple functions","volume":"21","author":"Dickey","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.cellin.2026.100360_bib40","first-page":"47","article-title":"Low-dose radiation improves tumor immune microenvironment, enhancing the effects of Anti-CTLA-4 therapy","volume":"22","author":"Dong","year":"2025","journal-title":"Iranian Journal of Immunology"},{"issue":"13","key":"10.1016\/j.cellin.2026.100360_bib41","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3390\/cancers18132098","article-title":"Radiotherapy-associated systemic antitumor responses beyond the classical abscopal paradigm","volume":"18","author":"Dotsu","year":"2026","journal-title":"Cancers"},{"issue":"19","key":"10.1016\/j.cellin.2026.100360_bib42","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/0008-5472.CAN-14-1258","article-title":"Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade","volume":"74","author":"Dovedi","year":"2014","journal-title":"Cancer Research"},{"issue":"18","key":"10.1016\/j.cellin.2026.100360_bib43","doi-asserted-by":"crossref","first-page":"7241","DOI":"10.7150\/thno.97593","article-title":"ZNF131-BACH1 transcriptionally accelerates RAD51-dependent homologous recombination repair and therapy-resistance of non-small-lung cancer cells by preventing their degradation from CUL3","volume":"14","author":"Fan","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.cellin.2026.100360_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104745","article-title":"TGF-\u03b2 in radiotherapy: Mechanisms of tumor resistance and normal tissues injury","volume":"155","author":"Farhood","year":"2020","journal-title":"Pharmacological Research"},{"issue":"7","key":"10.1016\/j.cellin.2026.100360_bib45","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"International Journal of Cancer"},{"issue":"6","key":"10.1016\/j.cellin.2026.100360_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103464","article-title":"Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: Interim analysis of overall survival from PACIFIC-R","volume":"9","author":"Filippi","year":"2024","journal-title":"ESMO Open"},{"issue":"12","key":"10.1016\/j.cellin.2026.100360_bib47","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/j.cellin.2026.100360_bib48","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2174\/092986712800099811","article-title":"Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - Implications for cancer therapies","volume":"19","author":"Frey","year":"2012","journal-title":"Current Medicinal Chemistry"},{"issue":"6","key":"10.1016\/j.cellin.2026.100360_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171154","article-title":"PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice","volume":"134","author":"Frijlink","year":"2024","journal-title":"Journal of Clinical Investigation"},{"issue":"6730","key":"10.1016\/j.cellin.2026.100360_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/science.adq4510","article-title":"Decoding the molecular interplay of CD20 and therapeutic antibodies with fast volumetric nanoscopy","volume":"387","author":"Ghosh","year":"2025","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009832","article-title":"PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironment","volume":"13","author":"Godfroid","year":"2025","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.21037\/cco-23-55","article-title":"Boosted abscopal effect from radiotherapy and pembrolizumab in anaplastic thyroid cancer: A mini-review and case report","volume":"12","author":"Goh","year":"2023","journal-title":"Chinese Clinical Oncology"},{"issue":"7","key":"10.1016\/j.cellin.2026.100360_bib53","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1470-2045(15)00054-6","article-title":"Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: A proof-of-principle trial","volume":"16","author":"Golden","year":"2015","journal-title":"The Lancet Oncology"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib56","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1038\/s41467-024-49121-3","article-title":"Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: Phase II clinical trial","volume":"15","author":"Gong","year":"2024","journal-title":"Nature Communications"},{"issue":"7","key":"10.1016\/j.cellin.2026.100360_bib55","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jtho.2017.04.014","article-title":"Combined radiotherapy and Anti\u2013PD-L1 antibody synergistically enhances antitumor effect in non\u2013small cell lung cancer","volume":"12","author":"Gong","year":"2017","journal-title":"Journal of Thoracic Oncology"},{"key":"10.1016\/j.cellin.2026.100360_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123068","article-title":"A self-gelling hemostatic powder boosting radiotherapy-elicited NK cell immunity to combat postoperative hepatocellular carcinoma relapse","volume":"317","author":"Gong","year":"2025","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.cellin.2026.100360_bib57","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1097\/CM9.0000000000003268","article-title":"Global burden of lung cancer in 2022 and projected burden in 2050","volume":"137","author":"Guo","year":"2024","journal-title":"Chinese Medical Journal"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/1559325815611901","article-title":"Assessment of some immune parameters in occupationally exposed nuclear power plant workers","volume":"13","author":"Gyuleva","year":"2015","journal-title":"Dose-Response"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41420-024-02270-2","article-title":"Genomic predictors of radiation response: Recent progress towards personalized radiotherapy for brain metastases","volume":"10","author":"Harary","year":"2024","journal-title":"Cell Death Discovery"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2066609","article-title":"Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA)","volume":"11","author":"Hassel","year":"2022","journal-title":"OncoImmunology"},{"issue":"23","key":"10.1016\/j.cellin.2026.100360_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312761","article-title":"Regulation of the cell-intrinsic DNA damage response by the innate immune machinery","volume":"22","author":"Hayman","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discovery"},{"issue":"46","key":"10.1016\/j.cellin.2026.100360_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq3940","article-title":"Tumor-specific delivery of clickable inhibitor for PD-L1 degradation and mitigating resistance of radioimmunotherapy","volume":"10","author":"Hou","year":"2024","journal-title":"Science Advances"},{"issue":"6313","key":"10.1016\/j.cellin.2026.100360_bib64","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.aaf7532","article-title":"The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury","volume":"354","author":"Hu","year":"2016","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.cellin.2026.100360_bib65","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1158\/1078-0432.CCR-22-2592","article-title":"Efficacy and safety of stereotactic body radiotherapy combined with camrelizumab and apatinib in patients with hepatocellular carcinoma with portal vein tumor thrombus","volume":"29","author":"Hu","year":"2023","journal-title":"Clinical Cancer Research"},{"issue":"11","key":"10.1016\/j.cellin.2026.100360_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003290","article-title":"Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: An open-label single-arm, phase II trial","volume":"9","author":"Hua","year":"2021","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40644-024-00680-0","article-title":"Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy","volume":"24","author":"Huang","year":"2024","journal-title":"Cancer Imaging"},{"issue":"9","key":"10.1016\/j.cellin.2026.100360_bib69","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/IGC.0000000000000292","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy","volume":"24","author":"Hui","year":"2014","journal-title":"International Journal of Gynecological Cancer"},{"issue":"12","key":"10.1016\/j.cellin.2026.100360_bib68","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S1470-2045(19)30519-4","article-title":"Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): A randomised, controlled, phase 3 study","volume":"20","author":"Hui","year":"2019","journal-title":"The Lancet Oncology"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2004.02.007","article-title":"Pharmacogenetics of cytochrome P450 and its applications in drug therapy: The past, present and future","volume":"25","author":"Ingelman-Sundberg","year":"2004","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008229","article-title":"Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): A single-arm phase Ib clinical trial","volume":"12","author":"Jiang","year":"2024","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"8","key":"10.1016\/j.cellin.2026.100360_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007141","article-title":"Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck","volume":"11","author":"Johnson","year":"2023","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib73","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.canlet.2013.02.038","article-title":"Enhanced anti-cancer activity of human dendritic cells sensitized with gamma-irradiation-induced apoptotic colon cancer cells","volume":"335","author":"Kim","year":"2013","journal-title":"Cancer Letters"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib74","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","article-title":"Low-dose irradiation programs macrophage differentiation to an iNOS+\/M1 phenotype that orchestrates effective T cell immunotherapy","volume":"24","author":"Klug","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellin.2026.100360_bib76","doi-asserted-by":"crossref","DOI":"10.18632\/aging.204539","article-title":"Senescence-associated exosomes transfer miRNA-induced fibrosis to neighboring cells","author":"Lee","year":"2023","journal-title":"Aging"},{"issue":"3","key":"10.1016\/j.cellin.2026.100360_bib75","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: Changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib77","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12943-024-01970-8","article-title":"An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer","volume":"23","author":"Levy","year":"2024","journal-title":"Molecular Cancer"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib78","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s12072-022-10396-7","article-title":"Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: A single-arm trial","volume":"16","author":"Li","year":"2022","journal-title":"Hepatology International"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib79","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12885-023-10784-8","article-title":"First-line atezolizumab\/durvalumab plus platinum\u2013etoposide combined with radiotherapy in extensive-stage small-cell lung cancer","volume":"23","author":"Li","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12885-024-13379-z","article-title":"Elucidating the expression and role of cGAS in pan-cancer using integrated bioinformatics and experimental approaches","volume":"25","author":"Lian","year":"2025","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.cellin.2026.100360_bib81","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","article-title":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter","volume":"24","author":"Lim","year":"2022","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13045-021-01213-z","article-title":"Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990\u20132019","volume":"14","author":"Lin","year":"2021","journal-title":"Journal of Hematology & Oncology"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib82","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12943-024-02106-8","article-title":"Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: Biological mechanisms to clinical significance and implications","volume":"23","author":"Lin","year":"2024","journal-title":"Molecular Cancer"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib85","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7150\/ijbs.7.168","article-title":"Gamma-ray irradiation impairs dendritic cell migration to CCL19 by down-regulation of CCR7 and induction of cell apoptosis","volume":"7","author":"Liu","year":"2011","journal-title":"International Journal of Biological Sciences"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib87","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cac2.12412","article-title":"Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer","volume":"43","author":"Liu","year":"2023","journal-title":"Cancer Communications"},{"key":"10.1016\/j.cellin.2026.100360_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1496390","article-title":"Lactate: A rising star in tumors and inflammation","volume":"15","author":"Liu","year":"2024","journal-title":"Frontiers in Immunology"},{"issue":"10","key":"10.1016\/j.cellin.2026.100360_bib84","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.cmet.2021.07.009","article-title":"Innate immune response orchestrates phosphoribosyl pyrophosphate synthetases to support DNA repair","volume":"33","author":"Liu","year":"2021","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.cellin.2026.100360_bib164","article-title":"Adagrasib treatment after Sotorasib-related hepatotoxicity in patients with KRASG12C-mutated non\u2013small cell lung cancer: a case series and literature review","volume":"8","author":"Luo","year":"2024","journal-title":"JCO Precision Oncolog"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib89","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1189\/jlb.3A1015-474R","article-title":"Stromal fibroblasts support dendritic cells to maintain IL-23\/Th17 responses after exposure to ionizing radiation","volume":"100","author":"Malecka","year":"2016","journal-title":"Journal of Leukocyte Biology"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib90","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1200\/JCO.20.00290","article-title":"Randomized phase II trial of nivolumab with stereotactic body radiotherapy versus nivolumab alone in metastatic head and neck squamous cell carcinoma","volume":"39","author":"McBride","year":"2021","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib91","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.cellin.2026.100360_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100940","article-title":"Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations","volume":"46","author":"McMahon","year":"2023","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093650","article-title":"Cranial irradiation alters the brain's microenvironment and permits CCR2+ macrophage infiltration","volume":"9","author":"Morganti","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib95","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41392-024-02036-3","article-title":"New insights into protein\u2013protein interaction modulators in drug discovery and therapeutic advance","volume":"9","author":"Nada","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"Supplement_1","key":"10.1016\/j.cellin.2026.100360_bib96","doi-asserted-by":"crossref","first-page":"i52","DOI":"10.1093\/jrr\/rrae081","article-title":"DNA double-strand break repair capacity and normal tissue toxicity induced by radiotherapy","volume":"65","author":"Nishibuchi","year":"2024","journal-title":"Journal of Radiation Research"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib97","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13075-025-03514-x","article-title":"Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg\/kg every 4 weeks in patients with rheumatoid arthritis: A prospective cohort study","volume":"27","author":"Onishi","year":"2025","journal-title":"Arthritis Research & Therapy"},{"issue":"21","key":"10.1016\/j.cellin.2026.100360_bib98","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1158\/1078-0432.CCR-18-1038","article-title":"Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation and regulatory T-Cell infiltration","volume":"24","author":"Oweida","year":"2018","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib99","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00262-020-02701-w","article-title":"Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide","volume":"70","author":"Oweida","year":"2021","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2007.08.017","article-title":"Activation of invariant NKT cells by toll-like receptor 9-Stimulated dendritic cells requires type I interferon and charged glycosphingolipids","volume":"27","author":"Paget","year":"2007","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib101","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.1038\/s41467-024-53704-5","article-title":"Perioperative Tislelizumab plus intensity modulated radiotherapy in resectable hepatocellular carcinoma with macrovascular invasion: A phase II trial","volume":"15","author":"Pan","year":"2024","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/bio.70168","article-title":"Spectroscopic visualization of drug\u2013biomolecules interactions: An insight to fluorescence quenching as tool in drug discovery","volume":"40","author":"Pandey","year":"2025","journal-title":"Luminescence"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib103","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nature Reviews Cancer"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib104","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2015.03.003","article-title":"The effect of ionizing radiation on regulatory T cells in health and disease","volume":"368","author":"Persa","year":"2015","journal-title":"Cancer Letters"},{"issue":"8","key":"10.1016\/j.cellin.2026.100360_bib105","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ccell.2025.06.008","article-title":"The dark side of radiotherapy","volume":"43","author":"Piffk\u00f3","year":"2025","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib106","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/1078-0432.CCR-21-2767","article-title":"Targeting treg-expressed STAT3 enhances NK-Mediated surveillance of metastasis and improves therapeutic response in pancreatic adenocarcinoma","volume":"28","author":"Piper","year":"2022","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.cellin.2026.100360_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108213","article-title":"Multivalent protein\u2013drug conjugates \u2013 An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells","volume":"67","author":"Por\u0119bska","year":"2023","journal-title":"Biotechnology Advances"},{"issue":"12","key":"10.1016\/j.cellin.2026.100360_bib108","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: The first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib109","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1038\/s41467-023-40844-3","article-title":"Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors","volume":"14","author":"Rudqvist","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.cellin.2026.100360_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2013.00157","article-title":"The irradiated tumor microenvironment: Role of tumor-associated macrophages in vascular recovery","volume":"4","author":"Russell","year":"2013","journal-title":"Frontiers in Physiology"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib111","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/1061186X.2024.2445772","article-title":"Decoding the complex web: Cellular and molecular interactions in the lung tumour microenvironment","volume":"33","author":"Saeed Issa","year":"2025","journal-title":"Journal of Drug Targeting"},{"issue":"13","key":"10.1016\/j.cellin.2026.100360_bib112","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr4008","article-title":"Systemic antitumor immune response of doped yttria nanoscintillators under low-dose x-ray irradiation","volume":"11","author":"Sahin","year":"2025","journal-title":"Science Advances"},{"issue":"6","key":"10.1016\/j.cellin.2026.100360_bib113","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nature Reviews Cancer"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib114","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(21)00658-6","article-title":"Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: An open-label, multicentre, randomised, phase 2 trial","volume":"23","author":"Schoenfeld","year":"2022","journal-title":"The Lancet Oncology"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/2326-6066.CIR-14-0196","article-title":"Stereotactic radiation therapy augments antigen-specific PD-1-Mediated antitumor immune responses via cross-presentation of tumor antigen","volume":"3","author":"Sharabi","year":"2015","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.cellin.2026.100360_bib116","first-page":"34","article-title":"The inhibiting effect of a low-dose ionizing radiation on the primary humoral immunity in the early period of a postnatal ontogeny","volume":"46","author":"Sharetskii","year":"2006","journal-title":"Radiatsionnaia Biologiia, Radioecologiia"},{"issue":"10","key":"10.1016\/j.cellin.2026.100360_bib117","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1158\/2159-8290.CD-23-1145","article-title":"Targeting acute myeloid leukemia stem cells through perturbation of mitochondrial calcium","volume":"14","author":"Sheth","year":"2024","journal-title":"Cancer Discovery"},{"issue":"3","key":"10.1016\/j.cellin.2026.100360_bib118","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ijrobp.2020.09.053","article-title":"Differential immune modulation with carbon-ion versus photon therapy","volume":"109","author":"Spina","year":"2021","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10.1016\/j.cellin.2026.100360_bib119","doi-asserted-by":"crossref","DOI":"10.1172\/JCI33249","article-title":"Sustained activation and tumor targeting of NKT cells using a CD1d\u2013anti-HER2\u2013scFv fusion protein induce antitumor effects in mice","author":"Stirnemann","year":"2008","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.cellin.2026.100360_bib120","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/ijms26020848","article-title":"Proteins and DNA sequences interacting with tanshinones and tanshinone derivatives","volume":"26","author":"Szymczyk","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.388","article-title":"Double-strand DNA break repair: Molecular mechanisms and therapeutic targets","volume":"4","author":"Tan","year":"2023","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib122","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1038\/s41467-022-34403-5","article-title":"The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction","volume":"13","author":"Tang","year":"2022","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib123","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.annonc.2022.10.006","article-title":"Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): A multicenter, randomized, phase II trial","volume":"34","author":"Tao","year":"2023","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib124","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/CJI.0b013e318163628c","article-title":"Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy","volume":"31","author":"Teitz-Tennenbaum","year":"2008","journal-title":"Journal of Immunotherapy"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(20)30391-X","article-title":"Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: A pooled analysis of two randomised trials","volume":"9","author":"Theelen","year":"2021","journal-title":"The Lancet Respiratory Medicine"},{"issue":"11","key":"10.1016\/j.cellin.2026.100360_bib126","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1080\/17425255.2021.1998455","article-title":"Novel models for the prediction of drug\u2013gene interactions","volume":"17","author":"T\u00fcrk","year":"2021","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"issue":"7547","key":"10.1016\/j.cellin.2026.100360_bib127","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/children8040266","article-title":"The relationship between COVID-19 and innate immunity in children: A review","volume":"8","author":"Valentini","year":"2021","journal-title":"Children"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib129","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40487-024-00309-z","article-title":"Stereotactic radiotherapy plus nivolumab in patients with locally advanced pancreatic cancer: Results from phase 1\/2 clinical CA209-9KH trial","volume":"12","author":"Vo\u0161mik","year":"2024","journal-title":"Oncology and Therapy"},{"issue":"8","key":"10.1016\/j.cellin.2026.100360_bib130","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1007\/s13277-016-4916-2","article-title":"The clinical and prognostic significance of CD14+HLA-DR\u2212\/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy","volume":"37","author":"Wang","year":"2016","journal-title":"Tumor Biology"},{"issue":"20","key":"10.1016\/j.cellin.2026.100360_bib131","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1158\/0008-5472.CAN-09-1976","article-title":"Protein kinase CK2 regulates cytoskeletal reorganization during ionizing radiation\u2013induced senescence of human mesenchymal stem cells","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib134","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1481114","article-title":"The immunoregulatory effect of aconite treatment on H22 tumor-bearing mice via modulating adaptive immunity and natural killer-related immunity","volume":"2023","author":"Wang","year":"2023","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"5","key":"10.1016\/j.cellin.2026.100360_bib136","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211631","article-title":"CCR2\/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma","volume":"219","author":"Wang","year":"2022","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cellin.2026.100360_bib137","article-title":"Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study","volume":"14","author":"Wang","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"7","key":"10.1016\/j.cellin.2026.100360_bib133","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232101","article-title":"Radiotherapy and immunology","volume":"221","author":"Wang","year":"2024","journal-title":"Journal of Experimental Medicine"},{"issue":"11","key":"10.1016\/j.cellin.2026.100360_bib135","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/cac2.70053","article-title":"Harnessing chimeric antigen receptor macrophages against solid tumors","volume":"45","author":"Wang","year":"2025","journal-title":"Cancer Communications"},{"issue":"22","key":"10.1016\/j.cellin.2026.100360_bib132","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1158\/1078-0432.CCR-24-1236","article-title":"Chemoradiotherapy and subsequent immunochemotherapy as conversion therapy in unresectable locally advanced esophageal squamous cell carcinoma: A phase II NEXUS-1 trial","volume":"30","author":"Wang","year":"2024","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.cellin.2026.100360_bib138","article-title":"Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC","volume":"14","author":"Wang","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"58","key":"10.1016\/j.cellin.2026.100360_bib139","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg0117","article-title":"Sequence of \u03b1PD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses","volume":"6","author":"Wei","year":"2021","journal-title":"Science Immunology"},{"issue":"9668","key":"10.1016\/j.cellin.2026.100360_bib140","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(09)60251-8","article-title":"Monoclonal antibodies for cancer immunotherapy","volume":"373","author":"Weiner","year":"2009","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib141","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/0008-5472.CAN-17-1788","article-title":"NKG2D-Based CAR T cells and radiotherapy exert synergistic efficacy in glioblastoma","volume":"78","author":"Weiss","year":"2018","journal-title":"Cancer Research"},{"issue":"9","key":"10.1016\/j.cellin.2026.100360_bib142","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s43587-024-00662-8","article-title":"The genetic architecture of biological age in nine human organ systems","volume":"4","author":"Wen","year":"2024","journal-title":"Nature Aging"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib143","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40425-019-0542-z","article-title":"Radiotherapy enhances responses of lung cancer to CTLA-4 blockade","volume":"7","author":"Wilkins","year":"2019","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib146","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12964-023-01139-8","article-title":"Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: Synergistic mechanisms, current state, challenges, and orientations","volume":"21","author":"Wu","year":"2023","journal-title":"Cell Communication and Signaling"},{"key":"10.1016\/j.cellin.2026.100360_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1431684","article-title":"Unveiling potential drug targets for lung squamous cell carcinoma through the integration of druggable genome and genome-wide association data","volume":"15","author":"Wu","year":"2024","journal-title":"Frontiers in Genetics"},{"issue":"7","key":"10.1016\/j.cellin.2026.100360_bib145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/cac2.12576","article-title":"Beyond success: Unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors","volume":"44","author":"Wu","year":"2024","journal-title":"Cancer Communications"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib147","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12943-025-02243-8","article-title":"Inflammation in cancer: Therapeutic opportunities from new insights","volume":"24","author":"Xie","year":"2025","journal-title":"Molecular Cancer"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib148","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1470-2045(24)00643-0","article-title":"Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): A multicentre, single-arm, phase 2 trial","volume":"26","author":"Xu","year":"2025","journal-title":"The Lancet Oncology"},{"issue":"10","key":"10.1016\/j.cellin.2026.100360_bib149","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/ijc.30235","article-title":"Low-dose radiation may be a novel approach to enhance the effectiveness of cancer therapeutics","volume":"139","author":"Yang","year":"2016","journal-title":"International Journal of Cancer"},{"issue":"15","key":"10.1016\/j.cellin.2026.100360_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202304328","article-title":"A hybrid nanoadjuvant simultaneously depresses PD-L1\/TGF-\u03b21 and activates cGAS-STING pathway to overcome radio-immunotherapy resistance","volume":"36","author":"Yi","year":"2024","journal-title":"Advanced Materials"},{"key":"10.1016\/j.cellin.2026.100360_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216219","article-title":"CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity","volume":"564","author":"Yu","year":"2023","journal-title":"Cancer Letters"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib152","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41392-020-0182-2","article-title":"MiR-410 induces both epithelial\u2013mesenchymal transition and radioresistance through activation of the PI3K\/mTOR pathway in non-small cell lung cancer","volume":"5","author":"Yuan","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"6","key":"10.1016\/j.cellin.2026.100360_bib153","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/occmed\/kqq062","article-title":"Biological effects of low-dose ionizing radiation exposure on interventional cardiologists","volume":"60","author":"Zakeri","year":"2010","journal-title":"Occupational Medicine"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib154","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13058-023-01641-4","article-title":"PKC-\u03b6 mediated reduction of the extracellular vesicles-associated TGF-\u03b21 overcomes radiotherapy resistance in breast cancer","volume":"25","author":"Zhang","year":"2023","journal-title":"Breast Cancer Research"},{"key":"10.1016\/j.cellin.2026.100360_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116371","article-title":"Emerging affinity methods for protein\u2013drug interaction analysis","volume":"249","author":"Zheng","year":"2024","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.cellin.2026.100360_bib156","doi-asserted-by":"crossref","first-page":"10173","DOI":"10.2147\/IJGM.S328810","article-title":"Influence of GSTP-1 polymorphism on the prognosis of patients with high-grade glioma who received temozolomide plus radiotherapy adjuvant treatment","volume":"14","author":"Zhi","year":"2021","journal-title":"International Journal of General Medicine"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib157","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2057892","article-title":"Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice","volume":"11","author":"Zhou","year":"2022","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.cellin.2026.100360_bib158","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41420-021-00731-6","article-title":"Carbon ion radiotherapy boosts anti-tumour immune responses by inhibiting myeloid-derived suppressor cells in melanoma-bearing mice","volume":"7","author":"Zhou","year":"2021","journal-title":"Cell Death Discovery"},{"issue":"20","key":"10.1016\/j.cellin.2026.100360_bib159","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1158\/1078-0432.CCR-23-0315","article-title":"Safety and tolerability of low-dose radiation and stereotactic body radiotherapy + sintilimab for treatment-na\u00efve stage IV PD-L1+ non\u2013small cell lung cancer patients","volume":"29","author":"Zhou","year":"2023","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.cellin.2026.100360_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1074477","article-title":"Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment","volume":"13","author":"Zhu","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2026.100360_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117414","article-title":"Discovery of novel and selective SIK2 inhibitors by the application of AlphaFold structures and generative models","volume":"91","author":"Zhu","year":"2023","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.cellin.2026.100360_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101764","volume":"55","author":"Zhu","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.cellin.2026.100360_bib163","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1470-2045(23)00060-8","article-title":"Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): A single-arm, phase 2 trial","volume":"24","author":"Zhu","year":"2023","journal-title":"The Lancet Oncology"}],"container-title":["Cell Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892726000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892726000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:53:04Z","timestamp":1791967984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772892726000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":162,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2772892726000635"],"URL":"https:\/\/doi.org\/10.1016\/j.cellin.2026.100360","relation":{},"ISSN":["2772-8927"],"issn-type":[{"value":"2772-8927","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From DNA damage to systemic immunity: Interaction networks in radio-immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cell Insight","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellin.2026.100360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier B.V. on behalf of Wuhan University.","name":"copyright","label":"Copyright"}],"article-number":"100360"}}